BAX News and Press, Baxter International Inc. From 11/07/25

Funding from the Baxter Foundation builds on 15+ year partnership with Northwestern University’s School of Education and Social Policy to promote engagement and confidence in Science, Technology, Engineering and Mathematics (STEM) for Chicagoland youth and professional development opportun...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options If you suffered losses in Baxter and would like to discuss your legal rights, call Faruq...

2025-11-04 16:58:13 ET The almost daily record close in the Nasdaq ( QQQ ) and S&P 500 ( IVV ) ( SP500 ) masked weakness in many stocks. In the last month, companies on either index and on my watchlist lost 10% or more. Among them, this article will focus on those who lo...

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in Baxter International, Inc. Lawsuit - BAX Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in Baxter International, Inc. Lawsuit - BAX PR Newswire ...

2025-11-04 08:30:00 ET Before the pandemic, Baxter International ( BAX ) was considered one of the better businesses in the health care space. At the end of 2019, BAX stock traded at about 25x that year's earnings per share, a significant premium to peers. Dan Loeb's Third Point Cap...

2025-11-03 07:50:42 ET Chart Of The Day: Is A Year-End S&P Run Incoming? Monthly Market Review: Is This A Bubble? S&P 500 Earnings: Check EPS Revisions For 2027 S&P 500: That Ain't A Top (Technical Analysis) The 3 Things That Could Derail This...

2025-11-02 09:05:47 ET More on The Health Care Select Sector SPDR® Fund ETF XLV: Lower Interest Rates And A Positive Growth Outlook Will Pave The Way XLV: Market Overreaction Could Drive Double Digit Shareholder Yield XLV Vs. IHE: Will Pharmaceuticals Outperform...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Baxter To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Baxter between February 23, 2022 and July 30,...

2025-11-01 13:40:53 ET More on Healthcare Moderna: Focus On Cancer Vaccines, Not Buyout AbbVie Inc. (ABBV) Q3 2025 Earnings Call Transcript AbbVie: Why Q3 Confirms Its Immunology Dominance Pfizer gets HSR early termination for planned Metsera deal Abb...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Baxter To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Baxter between February 23, 2022 and July 30,...